Dr. Fidler is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Connect with other colleagues in the same hospital or clinic
- Search all U.S. specialist profiles and refer a patient
- Read the latest clinical news and earn CME/CEU credits
Office
1725 W Harrison St
Suite 1010
Chicago, IL 60612Phone+1 312-942-5904- Is this information wrong?
Education & Training
Rush University Medical CenterFellowship, Hematology and Medical Oncology, 2004 - 2007
McGaw Medical Center of Northwestern UniversityResidency, Internal Medicine, 2001 - 2004
Albert Einstein College of MedicineClass of 2001
Certifications & Licensure
IL State Medical License 2001 - 2026- American Board of Internal Medicine Medical Oncology
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2011-2013
Clinical Trials
- Safety and Efficacy of Buparlisib (BKM120) in Patients With Untreated Squamous Non-small Cell Lung Cancer Start of enrollment: 2013 Sep 09
- Expanded Treatment Protocol With LDK378 in ALK(+) NSCLC
- Chemoradiation Plus Durvalumab Followed by Surgery Followed by Adjuvant Durvalumab in Patients With Surgically Resectable Stage III (N2) Non-Small Cell Lung Cancer Start of enrollment: 2019 Aug 02
Publications & Presentations
PubMed
- Disparities in outcomes between Black and White patients in North America with thoracic malignancies and COVID-19 infection (TERAVOLT).Laura Burns, Chih-Yuan Hsu, Jennifer G Whisenant, Melina E Marmarelis, Carolyn J Presley, Karen L Reckamp, Hina Khan, Mary Jo Fidler, Christine M Bestvina, Julie Brahm...> ;Lung Cancer. 2023 Dec 1
- A nationwide analysis of salvage surgery for laryngeal cancer in the elderly.Richard A Raad, Katie Holland, Ethan M Ritz, Bobby A Tajudeen, Samer Al-Khudari, Kerstin Stenson, Joshua Teitcher, Mary Jo Fidler, Michael Jelinek, Nikhil Joshi, Mihir...> ;Head & Neck. 2023 Nov 1
- 4 citationsThree-Year Safety, Tolerability, and Health-Related Quality of Life Outcomes of Adjuvant Osimertinib in Patients With Resected Stage IB to IIIA EGFR-Mutated NSCLC: Upd...Thomas John, Christian Grohé, Jonathan W Goldman, Frances A Shepherd, Filippo de Marinis, Terufumi Kato, Qun Wang, Wu-Chou Su, Jin Hyuk Choi, Virote Sriuranpong, Barba...> ;Journal of Thoracic Oncology. 2023 Sep 1
- Join now to see all
Press Mentions
Philip Bonomi, MD, Retiring from Clinical Service in JuneMay 30th, 2022- First Patient Enrolled in Biodesix and Addario Lung Cancer Medical Institute Study Aiming to Predict Patient Survival Using a Blood-Based BiomarkerMay 26th, 2021
- Biodesix, Addario Lung Cancer Institute Enroll First Patient in NSCLC Biomarker StudyMay 26th, 2021
- Join now to see all
Professional Memberships
- Member
Hospital Affiliations
Rush University Medical CenterChicago, Illinois
Rush Oak Park HospitalOak Park, Illinois
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
